OP0195 SELECTIVE EXPANSION OF REGULATORY T-CELLS IN HUMANS BY A NOVEL IL-2 CONJUGATE T-REG STIMULATOR, NKTR-358, BEING DEVELOPED FOR THE TREATMENT OF AUTOIMMUNE DISEASES
Christie Fanton(Nektar Therapeutics (United States)), Brian L. Kotzin(Howard Hughes Medical Institute), Toufigh Gordi(Nektar Therapeutics (United States)), Lin Lü(Nektar Therapeutics (United States)), Neha Dixit(Nektar Therapeutics (United States)), Jonathan Zalevsky(Nektar Therapeutics (United States)), Daniel Dickerson(PRA Health Sciences), Suresh Siddhanti(Amgen (United States))
Cited by 5
Related Papers
Denosumab for Prevention of Fractures in Postmenopausal Women with Osteoporosis
|New England Journal of Medicine|2009|3.5k
β-Arrestin–Dependent Endocytosis of Proteinase-Activated Receptor 2 Is Required for Intracellular Targeting of Activated Erk1/2
|The Journal of Cell Biology|2000|816
Enhanced antibody half-life improves in vivo activity
|Nature Biotechnology|2010|654
JNK and Tumor Necrosis Factor-α Mediate Free Fatty Acid-induced Insulin Resistance in 3T3-L1 Adipocytes
|Journal of Biological Chemistry|2005|403